The distribution of the other genotypes relating to MMP-2 and MMP-3 showed no significant difference (OR 1.16; 95% CI 0.66–2.04, OR 1.59; 95% CI 0.87–2.84, respectively) with respect to CRC-related death (Table 3). This evidence concerns the gene MMP2 and colorectal carcinoma.